We next examined individual genes and find that in luminal A breast cancers ENG, TGFBR3, INHA, and INHBA, were better performing as compared to INHBB particularly for taxane or anthracycline based chemotherapy regimens. This evidence concerns the gene TGFBR3 and breast cancer.